Skip to main content
Publications
Bogler O, Raissi A, Colacci M, Beaman A, Biering-Sorensen T, Cressman A, Detsky A, Gosset A, Lassen MH, Kandel C, Khaykin Y, Barbosa D, Lapointe-Shaw L, MacFadden DR, Pearson A, Perkins BA, Rothman KJ, Skaarup KG, Weagle R, Yarnell C, Sholzberg M, Hodzic-Santor B, Lovblom E, Zipursky J, Quinn KL, Fralick M. Association between diabetes and mortality among adult patients hospitalized with COVID-19: a cohort study of hospitalized adults in Ontario, Canada, and Copenhagen, Denmark. Can J Diabetes. 2023 Jun;47(4):352-8. doi: 10.1016/j.jcjd.2023.02.005
Matharu M, Pascual J, Nisson Remahl I, Straube A, Lum A, Davar G, Odom D, Bennett L, Proctor C, Gutierrez L, Andrews E, Johannes C. Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe. Cephalalgia. 2017 Dec;37(14):1384-97. doi: 10.1177/0333102417724150
Matharu M, Pascual J, Nilsson Remahl L, Straube A, Johannes C, Odom D, Gutierrez L, Andrews E, Lum A. Interim analysis of the real-world utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine in an observational study in the European Union. Poster presented at the International Headache Conference; May 14, 2015. Valencia, Spain. [abstract] Cephalalgia. 2015; 35(6S):39.